Prostate Cancer Trial, Recruiting NCT06923657 Sponsor: First Affiliated Hospital of Fujian Medical University Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06923657
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose blood test shows a PSA (prostate-specific antigen) level above 4 ng/mL
  • People who have had at least one prostate biopsy in the past that came back negative (no cancer found)
  • People whose PSA levels, and/or PHI (a related prostate health marker) levels, have gone up at least two times in a row
  • People whose physical prostate examination (a rectal exam performed by a doctor) showed no abnormalities
  • People whose detailed prostate MRI scan returned a score of 3 or lower on a standard scale used to assess cancer risk (called PI-RADS)

Who may not be able to join:

  • People who are 30 years old or younger, or older than 85 years old
  • People who currently have another type of cancer
  • People who have previously received any cancer treatment or had prostate surgery (note: having had a prostate biopsy does not count as an exclusion)
  • People who are unable to undergo a specific type of scan called a PSMA PET/MRI — for example, due to allergies to contrast dye or claustrophobia (fear of enclosed spaces)
  • People for whom a prostate biopsy would be medically unsafe — for example, due to blood clotting problems, active prostate inflammation, or an active urinary tract infection
  • People with serious problems affecting major organs such as the heart, lungs, liver, or kidneys
  • People whose medical or test records are incomplete

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13235907575

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Fujian Medical University
Registry
ClinicalTrials.gov
Start date
7 May 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic Sensitivity; Diagnostic Specificity; Positive Predictive Value(PPV); Negative Predictive Value(NPV); Positive Likelihood Ratio(PLR); Negative Likelihood Ratio(NLR); Correct Diagnostic Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov